Prevalence of abnormal glucose tolerance in hypertensive patients
Main Article Content
Keywords
Hypertension, Impaired glucose tolerance, Cardiovascular risk, Diabetes mellitus
Abstract
Background: Type 2 diabetes mellitus is commonly associated with hypertension; the standard oral glucose load is an independent risk factor for cardiovascular disease. The aim of this research is to show the prevalence of abnormal glucose tolerance in hypertensive patients with normal fasting glucose.
Methods: We enrolled 65 hypertensive non diabetic patients with fasting glucose < 100 mg/dL. In all of them a standard glucose load was performed.
Results: We found abnormal glucose tolerance in 32 patients (49.2 %), 29 individuals with impaired glucose tolerance, and three of them with a diabetic curve. We did not find any relation between abnormal glucose tolerance with blood pressure; however, we found a significant positive correlation between abnormal glucose tolerance and body mass index > 32.6 (R = 0.59, p < 0.005, OR 4.2).
Conclusion: Our results shown that abnormal glucose tolerance is common in hypertensive non-diabetic patients, especially in those with increased body mass index, and that fasting glucose is not an accurate screening test for diabetes in those patients.
References
Rojas R, Jiménez A, Barquera S, Campos I, Gutierrez JP, Hernandez L. Diabetes, hipertensión e hipercolesterolemia. En Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernandez S, Franco A, Cuevas-Nasu L, Romero-Martinez M, Hernandez-Ávila M. Editores. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, Mexico: Ediciones del Instituto Nacional de Salud Pública; 2012. pp 91.
Segura J, de la Sierra A, Fernández S, Ruilope LM, en representación de los investigadores del estudio IDENTCARE. Influencia de la diabetes sobre la prevalencia de lesión de órganos diana y enfermedad cardiovascular en los pacientes hipertensos de alto riesgo. Med Clin (Barc). 2013;141:287-91.
American Diabetes Association. Standards of medical care in Diabetes-2013. Diabetes care. 2013;36: S11-S66.
Burke JP, Gonzalez C, Williams K, Stern MP, Haffner SM. Elevated incidence of type 2 diabetes in San Antonio Texas compared with that of Mexico City. Diabetes care. 2001;24:1573-8.
Salmasi AM, Alimo A, Dancy M. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic. Am J hypertens. 2004;17:483‑8.
U.S. Preventive Service Task Force. Screening for type 2 diabetes mellitus in adults: Recommendations and rationale. Ann Intern Med. 2003;138:212-4.
Rubio-Guerra AF, Durán Salgado MB. Insulina, sistema renina-angiotensina-aldosterona y disfuncion endotelial. Rev Med Inst Mex Seguro Soc. 2011;49: 581-4.
Li ZY, Wang P, Miao CY. Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol. 2011;38:888-96.
Garancini MP, Calori G, Ruotolo G, Manara E, Izzo A, Ebbli E, et al. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia. 1995;38:306-13.
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM trial. JAMA. 2003;290:486-94.